FDA Extends Comment Period for Common Rule Harmonization Regulations by One Month

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA Extends Comment Period for Common Rule Harmonization Regulations by One Month

J.W. Schomisch

November 16, 2022 at 08:48 AM EST

The FDA extended the comment period for an additional month on proposed regulations that are designed to harmonize FDA rules with the revised Common Rule. The comment period was extended to 11:59 p.m. EST on Dec. 28 “in response to requests for an extension to allow interested persons additional time to submit comments” on two proposed regulations. “The requests conveyed con... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA Extends Comment Period for Common Rule Harmonization Regulations by One Month

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA Extends Comment Period for Common Rule Harmonization Regulations by One Month

My Research Folders

Related Articles

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT